US4483807A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Process for producing a slow release composite
Assignee: Japan Atomic Energy Agency
•
Filing: 1982-01-20
•
Granted: 1984-11-20
•
Expires: 2002-01-20
Abstract
Abstract A process is herein disclosed for producing a slow release composite comprising grinding and mixing mechanically in a frozen state one or more polypeptides, one or more proteins and one or more physiologically active substances shaping the blend into a desired form and compressing at a pressure of from 100 to 20,000 kg/cm2 to thereby produce a slow release composite having the physiologically active substances encapsulated therein.
Inventors
- 👤 Masaharu Asano
- 👤 Masaru Yoshida
- 👤 Isao Kaetsu
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 02:19
CPC Classifications
C; C08; C08L; C08L89/00; A; A01; A01N; A01N25/00; A01N25/08; A01N25/10; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2031; A61K9/2045; A61K9/2063; Y; Y10; Y10T; Y10T428/00; Y10T428/24; Y10T428/24628; Y10T428/24653
Claims Analysis
Total Claims: 8
Claim 1
Independent Claim
183 words
A process for producing a slow release composite having a physiologicaly active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, and one or more physiologically active substances is ground into particles and mixed mechanicaly in a frozen state, the blend is shaped into a suitable form, and the shaped article is compressed into a suitable form at a pressure of from 100 to 20,000 kg/cm 2 .
Claim 2
Dependent Claim
183 words
A process for producing a slow release composite having a physiologicaly active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, and one or more physiologically active substances is ground into particles and mixed mechanicaly in a frozen state, the blend is shaped into a suitable form, and the shaped article is compressed into a suitable form at a pressure of from 100 to 20,000 kg/cm 2 .
Claim 3
Dependent Claim
211 words
A process for producing a slow release composite having physiologically active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, and one or more physiologically active substances is ground into particles and mixed mechanically in a frozen state, the blend is shaped into a suitable the shaped article is compressed into a suitable form at a pressure of from 100 to 20,000 kg/cm 2 , said shaped article being irradiated with light or ionizing radiation as it is compressed or after it has been compressed at a pressure of from 100 to 20,000 kg/cm 2 .
Claim 4
Dependent Claim
211 words
A process for producing a slow release composite having physiologically active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, and one or more physiologically active substances is ground into particles and mixed mechanically in a frozen state, the blend is shaped into a suitable the shaped article is compressed into a suitable form at a pressure of from 100 to 20,000 kg/cm 2 , said shaped article being irradiated with light or ionizing radiation as it is compressed or after it has been compressed at a pressure of from 100 to 20,000 kg/cm 2 .
Claim 5
Dependent Claim
172 words
A process for producing a slow release composite having physiologically active substance encpsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-aniline, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine. one or more physiologically active substances, and a suitable mixture of water and an organic solvent is shaped into a suitable form, and the shaped article is heated at a temperature between room temperature and 100° C.
Claim 6
Dependent Claim
172 words
A process for producing a slow release composite having physiologically active substance encpsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-aniline, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine. one or more physiologically active substances, and a suitable mixture of water and an organic solvent is shaped into a suitable form, and the shaped article is heated at a temperature between room temperature and 100° C.
Claim 7
Dependent Claim
185 words
A process for producing a slow release composite having a physiologically active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, one or more physiologically active substances, and a suitable mixture of water and an organic solvent is shaped into a suitable form, and the shaped article is heated at a temperature between room temperature and 100° C., and the heated product is further irradiated with light or ionizing radiation.
Claim 8
Dependent Claim
185 words
A process for producing a slow release composite having a physiologically active substance encapsulated therein, wherein a system comprising one or more polypeptides selected from the group consisting of poly-alanine, poly-glycine, poly-valine, poly-leucine, polyisoleucine, poly-serine, poly-o-benzyl-serine, poly-threonine, poly-o-benzyl-threonine, poly-cysteine, poly-s-benzyl-cysteine, poly-cystine, poly-methionine, poly-proline, poly-oxyproline, poly-aspartic acid, poly-β-benzyl-aspartic acid, poly-glutamic acid, poly-γ-benzyl-glutamic acid, poly-γ-methyl-glutamic acid, poly-histidine, poly-lysine, poly-oxylysine, poly-ornithine, poly-arginine, poly-nitroalginine, poly-phenylalanine, poly-tyrosine, poly-o-benzyl-tyrosine, and polytryptophan, one or more proteins selected from the group consisting of starch, beta-globulin, gamma-globulin, albumen albumin, milk albumin, bovine serum albumin, human serum albumin, other serum albumins, leucosin, hemoglobin, globin, alpha-lipoprotein, beta-lipoprotein, fibrinogen, ovalbumin, conalbumin euglobulin, pseudoglobulin, glutenin, gliadin, insulin, glutathione, pectin, albumen, prolamine, glutelin, histone, protamine, metaprotein, peptone, myoglobin, ferritin, bacteriorhodopsin, rubredoxin, chymotrypsin, ribonuclease, papain, thermolysin, thioredoxin, flavodoxin, hexokinase, phosphorylase, carboxypeptidase A, albumen lysozyme, cytochrome, thrombin, elastase, pepsin, elastin, and protamine, one or more physiologically active substances, and a suitable mixture of water and an organic solvent is shaped into a suitable form, and the shaped article is heated at a temperature between room temperature and 100° C., and the heated product is further irradiated with light or ionizing radiation.
References Cited (Backward Citations)
US3576758A
Cited
US3614851A
Cited
US3780195A
Cited
JPS49102827A
Cited
JPS5042025A
Cited
US4073835A
Cited
US4230687A
Cited
US4369784A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-11-20 | 1988-05-21 | 1988-11-20 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-11-20 | 1992-05-21 | 1992-11-20 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-11-20 | 1996-05-21 | 1996-11-20 | $7700.00 | Window Closed / Lapsed |